What is Avail Pharma?
Avail Pharma operates as the consulting division of AVAIL, established in June 1998. The firm leverages a team of highly-qualified consultants possessing proven analytical and problem-solving skills, coupled with deep knowledge in strategic pharmaceutical and biotechnological fields. Specialists in drug development, regulatory affairs, and international medical marketing bring over a decade of industry experience from key decision-making roles. Avail Pharma's core activities are augmented by an international network of external experts, including board-certified medical specialists, pharmaceutical physicians across various therapeutic areas, modeling and simulation experts, pharmacogenomic data specialists, statisticians, former health authority officers, and skilled regulatory and medical writers.
How much funding has Avail Pharma raised?
Avail Pharma has raised a total of $7.1M across 4 funding rounds:
Debt
$125K
Angel/Seed
$750K
Other Financing Round
$2M
Series A
$4.2M
Debt (2013): $125K, investors not publicly disclosed
Angel/Seed (2015): $750K led by Steve Olechowski and Metaprop
Other Financing Round (2017): $2M supported by Sandalphon Capital,, Charmides Capital, Cultivation Capital, and M25 Group
Series A (2020): $4.2M featuring Cultivation Capital
Key Investors in Avail Pharma
Cultivation Capital
Cultivation Capital is a venture capital firm that invests in young companies with transformative ideas across various industries, including life sciences, software, agriculture, and geospatial technology. The firm provides capital resources and a vast network of partners to help startups navigate the challenges of hyper growth from Series Seed through Series B.
Charmides Capital
Charmides Capital is a venture capital firm located in Indiana that specializes in providing seed and Series A stage funding for tech companies in the Midwest. The firm focuses on identifying business-to-business software as a service companies with high growth potential and co-invests with institutional investors.
M25 Group
M25 Group is a London-based removals and storage company established in 2008, offering a range of services including residential and business moves, property clearance, and storage solutions. The company has adapted to various economic challenges and evolved to meet the diverse needs of its clients, providing a comprehensive service that emphasizes order and transparency.
What's next for Avail Pharma?
The recent major strategic investment of $4.2M signals Avail Pharma's readiness for significant scaling or the pursuit of new strategic initiatives. Given the company's established track record and the enterprise-level nature of its total funding, this capital injection is likely to be directed towards expanding its consulting capabilities, enhancing its service portfolio, or potentially entering new markets. The company's focus on drug development, regulatory affairs, and international marketing suggests that future growth may involve deeper penetration into global pharmaceutical markets or the development of specialized advisory services for emerging biotech firms. The consistent backing from investors like Cultivation Capital indicates confidence in Avail Pharma's business model and its capacity to navigate the complex pharmaceutical landscape.
See full Avail Pharma company page
